Patents
Licensing agreement is ongoing  with the regent of University of California. 
Proteolysis-resistant capsid of chimeric hepatitis e virus as an oral delivery vector
Summary

This invention provides a peptide/nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
US20120301494 A1
View Patent on Google
Multiple antigen delivery system using hepatitis e virus-like particle 
Summary

This invention provides a peptide / nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
WO2010099547 A1
View Patent on Google
Chemically activated nanocapsid functionalized for cancer targeting 
Summary
This invention provides modified capsid proteins which be used to form hepatitis E virus (HEV) nanoparticles having cysteine functional groups exposed on the outer-surface
WO2015179321 A3 
View Patent on Google
Staying Ahead
State-of-art technology in research
Mucosa-Based Drug Delivery Platform
A Path Towards Lifestyle Medicine